Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 14 studies | 30% ± 14% | |
brain | 12 studies | 32% ± 15% | |
kidney | 9 studies | 25% ± 8% | |
intestine | 9 studies | 32% ± 15% | |
eye | 9 studies | 28% ± 10% | |
peripheral blood | 6 studies | 21% ± 6% | |
heart | 4 studies | 22% ± 4% | |
liver | 4 studies | 36% ± 17% | |
adipose | 4 studies | 23% ± 5% | |
pancreas | 3 studies | 35% ± 2% | |
placenta | 3 studies | 29% ± 6% | |
uterus | 3 studies | 38% ± 16% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 2827.62 | 258 / 258 | 100% | 49.61 | 230 / 230 |
brain | 100% | 2915.07 | 2642 / 2642 | 100% | 47.81 | 705 / 705 |
esophagus | 100% | 2144.83 | 1445 / 1445 | 100% | 19.38 | 183 / 183 |
liver | 100% | 1437.23 | 226 / 226 | 100% | 30.92 | 406 / 406 |
prostate | 100% | 2484.82 | 245 / 245 | 100% | 38.05 | 502 / 502 |
thymus | 100% | 2604.62 | 653 / 653 | 100% | 53.64 | 605 / 605 |
uterus | 100% | 3757.88 | 170 / 170 | 100% | 54.70 | 459 / 459 |
lung | 100% | 2341.51 | 578 / 578 | 100% | 30.07 | 1153 / 1155 |
bladder | 100% | 2690.48 | 21 / 21 | 100% | 42.74 | 503 / 504 |
kidney | 100% | 3167.80 | 89 / 89 | 100% | 48.15 | 899 / 901 |
pancreas | 100% | 1382.32 | 327 / 328 | 100% | 42.37 | 178 / 178 |
breast | 100% | 2488.84 | 459 / 459 | 99% | 36.58 | 1112 / 1118 |
intestine | 100% | 2758.22 | 966 / 966 | 99% | 36.64 | 524 / 527 |
stomach | 100% | 1628.06 | 359 / 359 | 99% | 27.80 | 283 / 286 |
ovary | 100% | 4212.46 | 180 / 180 | 98% | 17.18 | 423 / 430 |
skin | 100% | 2627.29 | 1808 / 1809 | 98% | 35.67 | 462 / 472 |
adipose | 100% | 2447.78 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 37.36 | 29 / 29 |
spleen | 100% | 2962.84 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 31.58 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 38.53 | 1 / 1 |
blood vessel | 100% | 2462.50 | 1334 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1394.21 | 848 / 861 | 0% | 0 | 0 / 0 |
muscle | 98% | 1194.27 | 790 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 29.90 | 78 / 80 |
peripheral blood | 76% | 1072.58 | 705 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0008360 | Biological process | regulation of cell shape |
GO_0007155 | Biological process | cell adhesion |
GO_0044346 | Biological process | fibroblast apoptotic process |
GO_2000270 | Biological process | negative regulation of fibroblast apoptotic process |
GO_0008150 | Biological process | biological_process |
GO_0006338 | Biological process | chromatin remodeling |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0000812 | Cellular component | Swr1 complex |
GO_0005575 | Cellular component | cellular_component |
GO_0000776 | Cellular component | kinetochore |
GO_0005634 | Cellular component | nucleus |
GO_0003674 | Molecular function | molecular_function |
Gene name | CFDP1 |
Protein name | Craniofacial development protein 1 Craniofacial development protein 1 (Bucentaur) Bucentaur |
Synonyms | BCNT CENP-29 |
Description | FUNCTION: May play a role during embryogenesis. . |
Accessions | A0A0H5APX3 Q9UEE9 A0A0H5B9V7 H3BQ17 ENST00000566254.1 ENST00000283882.4 [Q9UEE9-1] A0A0H5AUJ9 J3KT89 ENST00000612761.1 ENST00000569341.1 A0A087WXQ2 |